Sutro Biopharma, Inc. (STRO) Financials

STRO Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 431.7 million 319.4 million
2023-06-30 464.9 million 310.2 million
2023-03-31 358.0 million 172.6 million
2022-12-31 406.9 million 189.9 million

STRO Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -33.8 million 6.0 million
2023-06-30 -32.8 million 6.7 million
2023-03-31 -61.9 million 6.0 million
2022-12-31 -27.2 million 5.9 million

STRO Net Income

No data available :(

STRO Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 355.2 million - 31.0 million
2023-06-30 391.6 million - 32.5 million
2023-03-31 276.5 million - 33.3 million
2022-12-31 334.4 million - 34.2 million

STRO Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 60.6 million
2023-06-30 60.3 million
2023-03-31 58.7 million
2022-12-31 50.7 million

STRO Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 328000 45.7 million 15.3 million -
2023-06-30 1.6 million 41.6 million 15.0 million -
2023-03-31 942000 39.4 million 15.5 million -
2022-12-31 3.4 million 43.1 million 14.7 million -

STRO Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 16.9 million 1.7 million
2023-06-30 10.4 million 2.4 million
2023-03-31 12.7 million 2.3 million
2022-12-31 8.6 million 2.2 million

STRO

Price: $4.24

52 week price:
2.01
6.13

Earnings Per Share: -1.78 USD

P/E Ratio: -1.61

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 223541

Market Capitalization: 313.2 million

Links: